The aim of this study was to monitor long‐term changes in bone mineral density (BMD) after
menopause and factors affecting BMD. The study population consisted of a random sample …

Background Cushing's syndrome is known as an important cause of secondary
osteoporosis, characterized by reduction of bone mineral density and potential occurrence …

Prevalence and risk factors of vertebral fractures in postmenopausal RA women were
assessed in 323 patients and compared with 660 age-matched women. Of patients, 24.15 …

Purpose Osteoporosis is a systemic skeletal disease with a consequent increase in fractures
rates. Osteoporosis may be primary which is related with normal aging, or secondary which …

Glucocorticoid‐induced osteoporosis is the third epidemic osteoporosis following
postmenopausal and senileosteoporosis. According to one study, salidroside made …

Background The inhibition of glucocorticoid (GC) on osteoblastic differentiation of bone
marrow stromal stem cells (BMSC) is an important pathway for GC to reduce bone formation …

As clusters of peptides or steroids capable of high-efficiency information transmission,
hormones have been substantiated to coordinate metabolism, growth, development, and …

Dystrophin alterations in the brain have been associated with an increased risk of epilepsy
in Becker and Duchenne muscular dystrophies (BMD and DMD). Moreover, an association …

Introduction: Glucocorticoid-induced osteoporosis is an underrecognized complication of
chronic glucocorticoid therapy characterized by a decrease in new bone formation. Anabolic …

In this study, the osteogenic properties and anti-osteoporosis activity of calcium
hydroxyapatite (HA) obtained from Katsuwonus pelamis tuna bone and water-soluble …